Search Results - "Lugui Qiu"

A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28

Teng Fang, Lanting Liu, Hao Sun, Xiaoyu Zhang, Xiyue Sun, Zhen Yu, Lixin Gong, Shiyi Xie, Yonglong Zhao, Yan Li, Lugui Qiu, Gang An, Bin He, Mu Hao

electronic resource

View item

Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study

Jennifer R. Brown, Jessica Li, Barbara F. Eichhorst, Nicole Lamanna, Susan M. O’Brien, Constantine S. Tam, Lugui Qiu, Ruiqi Huang, Yang Shi, Adam Idoine, Tommi Salmi, Aileen Cleary Cohen, Mazyar Shadman

electronic resource

View item; View item

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study

Ying Yu, Yuxi Li, Rui Cui, Yuting Yan, Fei Li, Yan Chen, Tingyu Wang, Xiaoli Hu, Yaqing Feng, Tengteng Yu, Yanshan Huang, Jingwen Sun, Rui Lyu, Wenjie Xiong, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Huijun Wang, Zhijian Xiao, Jianxiang Wang, Lugui Qiu, Shuhua Yi

electronic resource

View item

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma

Yi Wang, Yuting Yan, Dandan Shan, Jiawen Chen, Wei Liu, Tingyu Wang, Gang An, Weiwei Sui, Wenyang Huang, Wenjie Xiong, Huimin Liu, Qi Sun, Huijun Wang, Zhijian Xiao, Jianxiang Wang, Lugui Qiu, Dehui Zou, Shuhua Yi

electronic resource

View item; View item

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma

Jie Zha, Qinwei Chen, Wei Zhang, Hongmei Jing, Jingjing Ye, Huanhuan Liu, Haifeng Yu, Shuhua Yi, Caixia Li, Zhong Zheng, Wei Xu, Zhifeng Li, Zhijuan Lin, Lingyan Ping, Xiaohua He, Liling Zhang, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu

electronic resource

View item

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing

Lanting Liu, Hao Sun, Fangshuo Feng, Xiyue Sun, Jingyuan Ma, Rui Lv, Tengteng Yu, Linhai Ye, Xiuchun Li, Zhen Yu, Xiaoyu Zhang, Huaqing Jing, Yao Yao, Fengxia Ma, Lugui Qiu, Mu Hao

electronic resource

View item; View item; View item

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma

Wenqiang Yan, Chen Qiu, Jieqiong Zhou, Jingyu Xu, Jian Cui, Yuntong Liu, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Weiwei Sui, Shuhui Deng, Yan Xu, Dehui Zou, Weiping Yuan, Lugui Qiu, Mu Hao, Yajing Chu, Gang An

electronic resource

View item; View item; View item

Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma

Mingyuan Sun, Hongmei Jing, Xiaoyan Qu, Fei Dong, Yi Li, Zhaoyi Feng, Samira Ziti-Ljajic, Dorothee Semiond, Lingyu Li, Junyuan Qi, Lugui Qiu

electronic resource

View item

Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies

Sanfang Tu, Xiu Luo, Heng Mei, Yongxian Hu, Yang Liu, Ping Li, Dehui Zou, Ting Niu, Kailin Xu, Xi Zhang, Lugui Qiu, Lei Gao, Guangxun Gao, Li Zhang, Yimei Feng, Ying Wang, Mingfeng Zhao, Jianqing Mi, Ming Hou, Jianmin Yang, He Huang, Jianxiang Wang, Yu Hu, Weili Zhao, Depei Wu, Jun Ma, Yuhua Li, Wenbin Qian, Xiaojun Huang, Weidong Han, Aibin Liang, Yanjie Yin

electronic resource

View item; View item; View item

Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report

Lugui Qiu, Gang An, Weiwei Sui, Dehui Zou, Rui Lv, Shuhui Deng, Wenqiang Yan, Yu Xiong, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Jigang Xiao

electronic resource

View item; View item

Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features

Hesong Zou, Wei Liu, Yi Wang, Dandan Shan, Ting Xie, Ru Li, Huimin Liu, Wenyang Huang, Mingwei Fu, Tingyu Wang, Rui Lyu, Shuhui Deng, Weiwei Sui, Yan Xu, Shuhua Yi, Gang An, Lugui Qiu, Dehui Zou, Ting Gao, Xiuyuan Hao

electronic resource

View item; View item; View item

DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways

Lanting Liu, Dasen Gong, Hao Sun, Fangshuo Feng, Jie Xu, Xiyue Sun, Lixin Gong, Zhen Yu, Teng Fang, Yan Xu, Rui Lyu, Tingyu Wang, Wentian Wang, Wenzhi Tian, Lugui Qiu, Gang An, Mu Hao

electronic resource

View item; View item

Lymphoma cell-driven IL-16 is expressed in activated B-cell-like diffuse large Bcell lymphomas and regulates the pro-tumor microenvironment

Xuwen Guan, Yi Wang, Teng Fang, Jingya Wang, Ru Li, Mu Hao, Lugui Qiu, CAMS Innovation Fund for Medical Sciences (CIFMS)

electronic resource

View item; View item; View item

Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)

Gang An, Zheng Ge, Hongmei Jing, Jing Liu, Guoping Yang, Ru Feng, Zhongyuan Xu, Ming Qi, Jianping Wang, Juanjuan Song, Wei Zhou, Binbin Sun, Dian Zhu, Xi Chen, Canchan Cui, Lugui Qiu

electronic resource

View item; View item

Immunotherapy for multiple myeloma: new chances and hope

Jingyu Xu, Gang An, Lugui Qiu

electronic resource

View item; View item

Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies

Yuqin Song, Shang-Ju Wu, Zhixiang Shen, Donglu Zhao, Thomas Sau Yan Chan, Huiqiang Huang, Lugui Qiu, Jianyong Li, Tran-der Tan, Jun Zhu, Yongping Song, Wei-Han Huang, Weili Zhao, Herman Sung Yu Liu, Wei Xu, Naizhi Chen, Jun Ma, Cheng-Shyong Chang, Eric Wai Choi Tse

electronic resource

View item

LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma

Lixin Gong, Hao Sun, Lanting Liu, Xiyue Sun, Teng Fang, Zhen Yu, Weiwei Sui, Jingyu Xu, Tingyu Wang, Fangshuo Feng, Lei Lei, Wei Rui, Yuxuan Liu, Xueqiang Zhao, Gang An, Xin Lin, Lugui Qiu, Mu Hao

electronic resource

View item; View item; View item

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma

Wei Liu, Yan Xu, Yi Wang, Huijun Wang, Jun Wei, Lugui Qiu, Huimin Liu, Jianxiang Wang, Weiwei Sui, Yin Shi, Hesong Zou, Wenyang Huang, Shuhua Yi, Dehui Zou, Lianting Chen, Rui Lv, Kefei Wang, Wenjie Xiong, Shuhui Deng, Guangxin Peng, Yueshen Ma, Lulu Lv, Wenting Zheng

electronic resource

View item; View item

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma

Teng Fang, Hao Sun, Xiyue Sun, Yi He, Peixia Tang, Lixin Gong, Zhen Yu, Lanting Liu, Shiyi Xie, Tingyu Wang, Zhenshu Xu, Shuhua Yi, Gang An, Yan Xu, Guoqing Zhu, Lugui Qiu, Mu Hao

electronic resource

View item; View item

Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma

Chunmei Kuang, Meijuan Xia, Gang An, CuiCui Liu, Cong Hu, Jingyu Zhang, Zhenhao Liu, Bin Meng, Pei Su, Jiliang Xia, Jiaojiao Guo, Yinghong Zhu, Xing Liu, Xuan Wu, Yi Shen, Xiangling Feng, Yanjuan He, Jian Li, Lugui Qiu, Jiaxi Zhou, Wen Zhou

electronic resource

View item